$VICR

VINCIARELLI PATRIZIO sold $465K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,437 shares of VICOR CORP (VICR) at $323.28 ($0.46M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 2, 2026, 7:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The market may briefly react to insider selling, but 10b5-1 typically reduces the informational edge versus discretionary sales.

02

Market read

A single disclosed insider sale at a known price; no fundamental corporate action is described.

03

What to watch

The disclosure doesn’t indicate intent beyond the plan; without context on prior sales/buybacks or total insider ownership changes, signal quality is limited.

Relevance 6/10Novelty 6/10Timing: Filed June 2; sale executed June 1 (open-market 10b5-1)

Background

This is an SEC Form 4 insider transaction: the issuer’s Chairman and CEO sold shares under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold $464.6K of VICR shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any move would be more about broader tape/earnings expectations than this Form 4.

Evidence & confidence

The filing provides a specific sale size, date, and price, but 10b5-1 plans are designed to reduce timing-based interpretation.

Market effects

Minimal; this is company-specific insider activity rather than a sector/regulatory development.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or large insider sales can still coincide with management’s risk/reward view; traders may watch for clustering with other insider activity.

Key entities

  • VICOR CORP

    Subject of the insider transaction disclosure (Form 4).

  • VINCIARELLI PATRIZIO

    Chairman and CEO who executed the open-market sale.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: